FibroBiologics (FBLG) Invested Capital (2026)

FibroBiologics (FBLG) posted quarterly Invested Capital of $124000.0 for Q2 2026, down 49.59% on a QoQ basis from $246000.0 in Q1 2026.

FibroBiologics (FBLG) Invested Capital (2026) Analysis & Trends

FibroBiologics has reported Invested Capital for 1 years, with the latest figure at $124000.0 in Q2 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	190.90 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.45 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	380.00 Mn
10	FibroBiologics	8.97 Mn	8.97 Mn	-	124,000.00

Download Data

Date	Value
Jun 30, 2026	124,000.00
Mar 31, 2026	246,000.00